Data as of Oct 24
| +0.01 / +4.10%|
The 3 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 0.75. The median estimate represents a +293.70% increase from the last price of 0.25.
The current consensus among 3 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.